VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+4.68%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$223M
AUM Growth
-$41.4M
(-16%)
Cap. Flow
-$33.4M
Cap. Flow
% of AUM
-14.95%
Top 10 Holdings %
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47
Top Buys
| 1 |
The Mosaic Company
MOS
|
$2.75M |
| 2 |
STR
Sitio Royalties
STR
|
$2.32M |
| 3 |
Copel
ELP
|
$2.31M |
| 4 |
Vale
VALE
|
$2.26M |
| 5 |
Nutrien
NTR
|
$2.24M |
Top Sells
| 1 |
Boise Cascade
BCC
|
$2.62M |
| 2 |
Extra Space Storage
EXR
|
$2.49M |
| 3 |
Canadian Natural Resources
CNQ
|
$2.46M |
| 4 |
Imperial Oil
IMO
|
$2.45M |
| 5 |
Avient
AVNT
|
$2.42M |
Sector Composition
| 1 | Materials | 20.16% |
| 2 | Real Estate | 20.02% |
| 3 | Healthcare | 16.51% |
| 4 | Energy | 10.55% |
| 5 | Utilities | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVLO
351
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $71K | 0.03% |
1,051
-62
| -6% | -$4.19K |
|
352
Cue Biopharma
CUE
$60.3M
| $70K | 0.03% |
14,281
-844
| -6% | -$4.14K |
|
353
Oric Pharmaceuticals
ORIC
$1.05B
| $69K | 0.03% |
12,914
-763
| -6% | -$4.08K |
|
354
CytomX Therapeutics
CTMX
$346M
| $68K | 0.03% |
25,634
-1,516
| -6% | -$4.02K |
|
355
Novavax
NVAX
$1.27B
| $68K | 0.03% |
921
-54
| -6% | -$3.99K |
|
|
RUBY
356
DELISTED
Rubius Therapeutics, Inc
RUBY
| $66K | 0.03% |
12,052
-721
| -6% | -$3.95K |
|
357
Zymeworks
ZYME
$1.07B
| $64K | 0.03% |
9,749
-575
| -6% | -$3.78K |
|
358
Cartesian Therapeutics
RNAC
$260M
| $61K | 0.03% |
1,641
-97
| -6% | -$3.61K |
|
359
Recursion Pharmaceuticals
RXRX
$1.97B
| $60K | 0.03% |
8,321
-500
| -6% | -$3.61K |
|
|
SRNE
360
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $59K | 0.03% |
25,427
-1,501
| -6% | -$3.48K |
|
361
Precision BioSciences
DTIL
$59.3M
| $58K | 0.03% |
632
-37
| -6% | -$3.4K |
|
|
GRCL
362
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $58K | 0.03% |
24,728
-1,469
| -6% | -$3.45K |
|
|
GRTS
363
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $56K | 0.03% |
13,538
-808
| -6% | -$3.34K |
|
|
IMAB
364
I-MAB
IMAB
$355M
| $51K | 0.02% |
3,136
-189
| -6% | -$3.07K |
|
365
Akebia Therapeutics
AKBA
$801M
| $47K | 0.02% |
65,149
-3,866
| -6% | -$2.79K |
|
366
BridgeBio Pharma
BBIO
$9.91B
| $41K | 0.02% |
4,057
-247
| -6% | -$2.5K |
|
367
MEI Pharma
MEIP
$140M
| $39K | 0.02% |
3,231
-191
| -6% | -$2.31K |
|
368
BioAtla
BCAB
$29.3M
| $37K | 0.02% |
7,475
-437
| -6% | -$2.16K |
|
369
Annexon
ANNX
$236M
| $31K | 0.01% |
11,398
-680
| -6% | -$1.85K |
|
370
Aligos Therapeutics
ALGS
$74.7M
| $29K | 0.01% |
537
-31
| -5% | -$1.67K |
|
371
Kodiak Sciences
KOD
$452M
| $15K | 0.01% |
1,902
-111
| -6% | -$875 |
|
|
ALLK
372
DELISTED
Allakos
ALLK
| $11K | ﹤0.01% |
1,902
-112
| -6% | -$648 |
|
373
AES
AES
$9.12B
| – | – |
-83,155
| Closed | -$2.02M |
|
|
AIV
374
Aimco
AIV
$1.11B
| – | – |
-286,482
| Closed | -$2.21M |
|
375
Air Products & Chemicals
APD
$64.5B
| – | – |
-7,619
| Closed | -$2.32M |
|